Arbutus Biopharma
ABUS
#6192
Rank
S$1.12 B
Marketcap
S$5.86
Share price
-3.39%
Change (1 day)
34.75%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): S-$0.34

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is S-$0.33. In 2024 the company made an earnings per share (EPS) of S-$0.49 an increase over its 2023 EPS that were of S-$0.56.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.34-29.91%
2024S-$0.49-13.64%
2023S-$0.56-4.35%
2022S-$0.59-44.58%
2021S-$1.07-17%
2020S-$1.28-65.4%
2019S-$3.71138.84%
2018S-$1.55-22.44%
2017S-$2.00-78.45%
2016S-$9.30424.64%
2015S-$1.77-20.19%
2014S-$2.2287.96%
2013S-$1.18-142.59%
2012S$2.77-342.7%
2011S-$1.14-25.82%
2010S-$1.5447.8%
2009S-$1.04-43.55%
2008S-$1.85158.91%
2007S-$0.71-111.88%
2006S$6.00-552.53%
2005S-$1.33-71.77%
2004S-$4.70-14.48%
2003S-$5.50-8.95%
2002S-$6.0470.07%
2001S-$3.5548.01%
2000S-$2.40-38.54%
1999S-$3.90-24.6%
1998S-$5.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
S$0.90-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S-$0.07705-76.92% Bahamas